Holdings Inc. (NASDAQ: ARCT), a company specializing in mRNA medicines for infectious diseases and rare disorders, has appointed Dr. Moncef Slaoui as its Chair Designate. Dr. Slaoui, a notable figure ...

Arcturus Therapeutics (ARCT) announced the appointment of Moncef Slaoui as chair designate. Slaoui has been serving on the company’s board of ...

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...

Abzena (Cambridge, UK), the leading end-to-end integrated CDMO + CRO for complex biologics and bioconjugates, has today announced the appointment of Moncef Slaoui, PhD, to its Board of Directors. A ...

Kristen B. Slaoui, Ph.D., has served as the Chief Corporate Development Officer at Galderma, a leading global dermatology company, since 2020, and serves on the board of directors of Kinaset ...

Try refreshing your browser, or tap here to see other videos from our team. Kristen B. Slaoui, Ph.D., has served as the Chief Corporate Development Officer at Galderma, a leading global dermatology ...

Abzena, an end-to-end integrated CDMO + CRO for complex biologics and bioconjugates, has appointed Moncef Slaoui, PhD, to its Board of Directors. An accomplished leader in the biopharmaceutical ...